// App-Quantinova.ai

2583 : Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study.

Researchers

Presenter

  • Veronique Dieras

Principal Investigators

  • Thomas Bachelot

  • Mario Campone

  • Marta Jimenez

  • Diane Charlotte Imbs

  • Christophe Le Tourneau

  • Philippe Alexandre Cassier

  • Emmanuelle Bompas

  • Pierre Fumoleau

  • Sabine Noal

  • Christine Orsini

  • Etienne Chatelut

  • Nicolas Isambert

  • Florence Joly

Medical Centers

  • Center Georges-Francois Leclerc, Dijon, France

  • Centre Leon Berard, Lyon, FranceCentre Francois Baclesse, Caen, FranceDepartment of Medical Oncology - Institut de Cancerologie de lOuest, Nantes, France

  • Institut de Cancerologie de l'Ouest Paul Papin, Angers, France

  • Institut Curie, Paris Cedex, France

  • Dept. of Medical Oncology, Centre Francois Baclesse, Caen, France

  • Department of Medical Oncology, Institut Curie, Saint-Cloud, France

  • UNICANCER, Paris, France

  • Institut Claudius Regaud, Toulouse, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

  • Pazopanib

Outcome

  • Positive

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT01165385

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved